USANA Health Ownership
| USNA Stock | USD 27.31 0.23 0.84% |
Shares in Circulation | First Issued 2009-03-31 | Previous Quarter 19 M | Current Value 19 M | Avarage Shares Outstanding 25.2 M | Quarterly Volatility 4.5 M |
USANA |
USANA Stock Ownership Analysis
About 42.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.97. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. USANA Health Sciences has Price/Earnings To Growth (PEG) ratio of 0.83. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 23rd of November 2016. USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. Usana Health operates under Packaged Foods classification in the United States and is traded on New York Stock Exchange. It employs 1978 people. For more information please call Kevin Guest at 801 954 7100 or visit https://www.usana.com.Besides selling stocks to institutional investors, USANA Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different USANA Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align USANA Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
USANA Health Quarterly Liabilities And Stockholders Equity |
|
USANA Health Insider Trades History
About 42.0% of USANA Health Sciences are currently held by insiders. Unlike USANA Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against USANA Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of USANA Health's insider trades
USANA Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as USANA Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading USANA Health Sciences backward and forwards among themselves. USANA Health's institutional investor refers to the entity that pools money to purchase USANA Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-12-31 | 140.9 K | Northern Trust Corp | 2024-12-31 | 135.9 K | Citadel Advisors Llc | 2024-12-31 | 131.4 K | Jacobs Levy Equity Management, Inc. | 2024-12-31 | 129 K | Amvescap Plc. | 2024-12-31 | 116.4 K | Assenagon Asset Management Sa | 2024-12-31 | 108.3 K | Royal Bank Of Canada | 2024-12-31 | 101.5 K | Goldman Sachs Group Inc | 2024-12-31 | 100.5 K | Ubs Group Ag | 2024-12-31 | 85.4 K | Blackrock Inc | 2024-12-31 | 1.8 M | Vanguard Group Inc | 2024-12-31 | 1.5 M |
USANA Health Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific USANA Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on USANA Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases USANA Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
USANA Health Outstanding Bonds
USANA Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. USANA Health Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most USANA bonds can be classified according to their maturity, which is the date when USANA Health Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| UPC HLDG BV Corp BondUS90320LAG23 | View | |
| USAACA 3375 01 MAY 25 Corp BondUS90327QD891 | View | |
| US90327QD552 Corp BondUS90327QD552 | View | |
| US90320BAA70 Corp BondUS90320BAA70 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
USANA Health Corporate Filings
F4 | 13th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 7th of March 2025 An amendment to a previously filed Form 8-K | ViewVerify |
8K | 25th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 3rd of February 2025 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.74) | Earnings Share 2.19 | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.